Longfellow Investment Management’s ResMed RMD Stock Holding History

Longfellow Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8	Closed	-$2.06K	–	293
2025 Q2	$2.06K	Hold	8	–	–	﹤0.01%	222
2025 Q1	$1.79K	Hold	8	–	–	﹤0.01%	234
2024 Q4	$1.83K	Hold	8	–	–	﹤0.01%	234
2024 Q3	$1.95K	Hold	8	–	–	﹤0.01%	220
2024 Q2	$1.53K	Hold	8	–	–	﹤0.01%	219
2024 Q1	$1.58K	Hold	8	–	–	﹤0.01%	234
2023 Q4	$1.38K	Hold	8	–	–	﹤0.01%	215
2023 Q3	$1.18K	Hold	8	–	–	﹤0.01%	210
2023 Q2	$1.75K	Hold	8	–	–	﹤0.01%	221
2023 Q1	$1.75K	Hold	8	–	–	﹤0.01%	221
2022 Q4	$1.67K	Hold	8	–	–	﹤0.01%	230
2022 Q3	$2K	Hold	8	–	–	﹤0.01%	288
2022 Q2	$2K	Hold	8	–	–	﹤0.01%	301
2022 Q1	$2K	Hold	8	–	–	﹤0.01%	331
2021 Q4	$3K	Hold	8	–	–	﹤0.01%	327
2021 Q3	$3K	Hold	8	–	–	﹤0.01%	352
2021 Q2	$2K	Hold	8	–	–	﹤0.01%	381
2021 Q1	$2K	Hold	8	–	–	﹤0.01%	438
2020 Q4	$2K	Buy	+8	New	+$1.59K	﹤0.01%	458

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Longfellow Investment Management's RMD Position: Q3 2025 in Review

Longfellow Investment Management sold out of ResMed (RMD) in Q3 2025, closing a stake of 8 shares — an estimated $2.06K sold.

Longfellow Investment Management first reported a position in RMD in Q4 2020 and held it in 19 quarters. The position peaked at $3K in Q4 2021. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

Longfellow Investment Management reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
Longfellow Investment Management sold 8 ResMed shares in Q3 2025, an estimated $2.06K.
Longfellow Investment Management first reported a position in ResMed in Q4 2020 and held it in 19 quarters.
Longfellow Investment Management's ResMed position peaked at $3K in Q4 2021.
950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Longfellow Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.